Investigation of the role of adjacent amino acids to the 313-320 sequence of the αIIb subunit on platelet activation and fibrinogen binding to αIIbβ3

Platelets

Volumn 17, Issue 5, 2006, Pages 277-282

  Mitsios, John V ^a   Stamos, Georgios ^a   Rodis, Foteini I ^a   Tsironis, Loukas D ^a   Stanica, Maria Ruxandra ^a   Sakarellos, Constantinos ^a   Tsoukatos, Demokritos ^a   Tsikaris, Vassilios ^a   Tselepis, Alexandros D ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

IIb 3 receptor; Integrin inhibitors; Peptides; Platelet activation inhibitors

Indexed keywords

ADENOSINE DIPHOSPHATE; ALPHA2 BETA3 INTEGRIN; ALPHA2 INTEGRIN; AMINO ACID; FIBRINOGEN; PADGEM PROTEIN; PEPTIDE DERIVATIVE; PROTEIN SUBUNIT; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BIOLOGICAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; STATISTICAL SIGNIFICANCE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

FIBRINOGEN; FLOW CYTOMETRY; HUMANS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTEIN BINDING;

EID: 33747808268     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100500436713     Document Type: Article

References (24)

1. Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein IIb-IIIa complex. Blood 1988;71:831-843.
2. Sims PJ, Ginsberg MH, Plow EF, Shattil SJ. Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa complex. J Biol Chem 1991;266:7345-7352.
3. Savage B, Marzec UM, Chao BH, Harker LA, Maraganore JM, Ruggeri ZM. Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb. IIIa complex inhibits receptor function. J Biol Chem 1990;265:11766-11772.
4. Shattil SJ, Kashiwagi H, Pampori N. Integrin signaling: the platelet paradigm. Blood 1998;91:2645-2657.
5. Parise L. Integrin alpha(IIb)beta(3) signaling in platelet adhesion and aggregation. Curr Opin Cell Biol 1999;11:597-601.
6. Kloczewiak M, Timmons S, Hawiger J. Localization of a site interacting with human platelet receptor on carboxy-terminal segment of human fibrinogen gamma chain. Biochem Biophys Res Commun 1982;107:181-187.
7. Gartner TK, Taylor DB. The amino acid sequence Gly-Ala-Pro-Leu appears to be a fibrinogen binding site in the platelet integrin, glycoprotein IIb. Thromb Res 1990;60:291-309.
8. Taylor DB, Gartner TK. A peptide corresponding to GPIIb alpha 300-312, a presumptive fibrinogen gamma-chain binding site on the platelet integrin GPIIb/IIIa, inhibits the adhesion of platelets to at least four adhesive ligands. J Biol Chem 1992;267:11729-11733.
9. Biris N, Abatzis M, Mitsios JV, et al. Mapping the binding domains of the alpha(IIb) subunit. A study performed on the activated form of the platelet integrin alpha(IIb)beta(3). Eur J Biochem 2003;270:3760-3767.
10. Mitsios JV, Tambaki AP, Abatzis M, et al. Effect of synthetic peptides corresponding to residues 313-332 of the alphaIIb subunit on platelet activation and fibrinogen binding to alphaIIbbeta3. Eur J Biochem 2004;271:855-862.
11. Xiao T, Takagi J, Coller BS, Wang JH, Springer TA. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 2004;432:59-67.
12. Goudevenos J, Tselepis AD, Tsoukatos D, Grekas G, Kritikakos J, Sideris D. Platelet aggregability to platelet activating factor at rest and after exercise in patients with coronary artery disease. Eur Heart J 1995;16:1036-1043.
13. Xia Z, Wong T, Liu Q, Kasirer-Friede A, Brown E, Frojmovic MM. Optimally functional fluorescein isothiocyanate-labelled fibrinogen for quantitative studies of binding to activated platelets and platelet aggregation. Br J Haematol 1996;93:204-214.
14. Golden A, Brugge JS, Shattil SJ. Role of platelet membrane glycoprotein IIb-IIIa in agonist-induced tyrosine phosphorylation of platelet proteins. J Cell Biol 1990;111:3117-3127.
15. Derrick JM, Loudon RG, Gartner TK. Peptide LSARLAF activates alpha(IIb)beta3 on resting platelets and causes resting platelet aggregate formation without platelet shape change. Thromb Res 1998;89:31-40.
16. Derrick JM, Taylor DB, Loudon RG, Gartner TK. The peptide LSARLAF causes platelet secretion and aggregation by directly activating the integrin alphaIIbbeta3. Biochem J 1997;325:309-313.
17. Basani R, French D, Vilaire G, et al. A naturally occurring mutation near the amino terminus of alphaIIb defines a new region involved in ligand binding to alphaIIbbeta3. Blood 2000;95:180-188.
18. Taub R, Gould RJ, Garsky VM, et al. A monoclonal antibody against the platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibrinogen. J Biol Chem 1989;264:259-265.
19. Biris N, Stavrakoudis A, Politou AS, et al. The Ac-RGD-NH2 peptide as a probe of slow conformational exchange of short linear peptides in DMSO. Biopolymers 2003;69:72-86.
20. Tsikaris V, Sakarellos-Daitsiotis M, Tzovaras D, et al. Isomerization of the Xaa-Pro peptide bond induced by ionic interactions of arginine. Biopolymers 1996;38:673-682.
21. Stavrakoudis A, Bizos G, Eleftheriadis D, et al. A three-residue cyclic scaffold of non-RGD containing peptide analogues as platelet aggregation inhibitors: design, synthesis, and structure - function relationships. Biopolymers 2001;56:20-26.
22. Kostidis S, Stavrakoudis A, Biris N, Tsoukatos D, Sakarellos C, Tsikaris V. The relative orientation of the Arg and Asp side chains defined by a pseudodihedral angle as a key criterion for evaluating the structure-activity relationship of RGD peptides. J Pept Sci 2004;10:494-509.
23. Pierschbacher MD, Ruoslahti E. Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. J Biol Chem 1987;262:17294-17298.
24. Stanica RM, Rodis F, Tsoukatos D, Tselepis A, Tsikaris V. Influence of each amino acid moiety within the 313-320 CD41 derived sequence to its antiplatelet properties. J Pept Sci 2004;Suppl. 10:262.